What is Ixazomib?

Category: Prescription Drugs

Most popular types: Ninlaro


See also: Ixazomib-lenalidomide-dexamethasone (IRd) Ixazomib-Thalidomide-Low Dose Dexamethasone

Ixazomib is a proteasome inhibitor used in combination with other drugs (lenalidomide and dexamethasone) to treat multiple myeloma in patients who have tried at least one other treatment previously.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 2
Mild 0
None 1

Commonly reported side effects and conditions associated with Ixazomib

Side effect Patients Percentage
Diarrhea 1
Exploding headaches 1
Fatigue 1
Nausea 1

Why patients stopped taking Ixazomib

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 1
See 1 patient who's stopped taking Ixazomib


Stopped taking Ixazomib

Duration Patients Percentage
6 months - 1 year 1
Adherence Evaluations Percentage
Always 4
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 3
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 2
< $25 0
Not specified 2

What people switch to and from

Patients started taking Ixazomib after stopping:

Treatment Patients Percentage
Carfilzomib (Kyprolis) 2
Lenalidomide (Revlimid) 2
Pomalidomide (Pomalyst) 2
Bortezomib (Velcade) 1
Bortezomib-lenalidomide-dexamethasone (VRd) 1

Patients stopped taking Ixazomib and switched to:

Treatment Patients Percentage
Carfilzomib (Kyprolis) 1
Daratumumab (Darzalex) 1
Last updated:
There are no evaluations for Ixazomib.